Known information
- Holds a PhD
- Collaborates on basic and translational research of novel cell therapies through sponsored research agreements with Baylor College of Medicine's Center for Cell and Gene Therapy
About AlloVir
AlloVir is a biotechnology company specializing in the development of allogeneic, virus-specific T cell therapies designed to treat and prevent viral infections in immunocompromised patients, with a headquarters in Waltham, MA.